Early diagnosis of hepatocellular carcinoma by multiple microRNAs: Validity, efficacy, and cost-effectiveness

Journal of Clinical Oncology

Volumn 29, Issue 36, 2011, Pages 4745-4747

  Chen, Chien Jen ^a,b   Lee, Mei Hsuan ^a  

^a GENOMICS RESEARCH CENTER   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 122; MICRORNA 192; MICRORNA 21; MICRORNA 223; MICRORNA 26A; MICRORNA 27A; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; CANCER DIAGNOSIS; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; EDITORIAL; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VALIDITY;

CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS B, CHRONIC; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS;

EID: 84555197150     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.39.0054     Document Type: Editorial

References (16)

1. Chen CJ, Yu MW, Liaw YF: Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol 12:S294-S308, 1997
2. Huang YT, Jen CL, Yang HI, et al.: Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C. J Clin Oncol 29:3643-3650, 2011
3. Lee MH, Yang HI, Lu SN, et al.: Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: Long-term predictors from a community-based cohort study. J Clin Oncol 28:4587-4593, 2010
4. Bouvard V, Baan R, Straif K, et al.: A review of human carcinogens: Part B-Biological agents. Lancet Oncol 10:321-322, 2009
5. Chen CJ, Yang HI: Natural history of chronic hepatitis B REVEALed. J Gastroenterol Hepatol 26:628-638, 2011
6. Yang HI, Lu SN, Liaw YF, et al.: Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 347:168-174, 2002
7. Yang HI, Sherman M, Su J, et al.: Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. J Clin Oncol 28:2437-2444, 2010
8. Yang HI, Yuen MF, Chan HL, et al.: Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): Development and validation of a predictive score. Lancet Oncol 12:568-574, 2011
9. Zhang YJ, Wu HC, Shen J, et al.: Predicting hepatocellular carcinoma by detection of aberrant promoter methylation in serum DNA. Clin Cancer Res 13:2378-2384, 2007 (Pubitemid 46698587)
10. Esquela-Kerscher A, Slack FJ: Oncomirs: MicroRNAs with a role in cancer. Nat Rev Cancer 6:259-269, 2006
11. Budhu A, Jia HL, Forgues M, et al.: Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 47:897-907, 2008 (Pubitemid 351449681)
12. Ji J, Shi J, Budhu A, et al.: MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med 361:1437-1447, 2009
13. Jiang J, Gusev Y, Aderca I, et al.: Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res 14:419-427, 2008 (Pubitemid 351226109)
14. Li LM, Hu ZB, Zhou ZX, et al.: Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Res 70:9798-9807, 2010
15. Li W, Xie L, He X, et al.: Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma. Int J Cancer 123:1616-1622, 2008
16. Zhou J, Yu L, Gao X, et al.: Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin Oncol 29:4781-4788, 2011